Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is an emerging noninvasive approach for the treatment of oligometastases. Limited prospective evidence is available in breast cancer. OBJECTIVES: To determine the safety and feasibility of single fraction SABR for patients with bone only oli...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Steven, Tan, Jennifer, Savas, Peter, Bressel, Mathias, Kelly, Dianne, Foroudi, Farshad, Loi, Sherene, Siva, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375645/
https://www.ncbi.nlm.nih.gov/pubmed/31734589
http://dx.doi.org/10.1016/j.breast.2019.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375645/
https://www.ncbi.nlm.nih.gov/pubmed/31734589
http://dx.doi.org/10.1016/j.breast.2019.10.016

Ejemplares similares